Baseline clinical data of patients with retinal vein occlusion
| Mean±SD | Range | |
|---|---|---|
| Age (years) | 69.9±10.8 | 41–88 |
| Sex | 20 men/20 women | |
| Type of RVO (central/major branch/macular branch) | 10/18/12 | |
| Hypertension (+/–) | 25/15 | |
| Refractive error (dioptres) | −1.050±2.831 | −5.250–2.500 |
| Visual acuity (logMAR units (Snellen equivalents)) | 0.435±0.368 (20/54) | −0.176–1.398 |
| Axial length (mm) | 24.18±1.52 | 22.03–25.12 |
| CRT (μm) | 580.5±191.7 | 334.0–1155.0 |
| Number of IVA injections | 3.1±0.9 | 2–5 |
| Recurrence (+/–) | 17/23 |
The number of IVA injections was defined as total injections during the 6 months of follow-up from the baseline.
CRT, central retinal thickness; IVA, intravitreal aflibercept; logMAR, logarithm of the minimum angle of resolution; RVO, retinal vein occlusion.